Cargando…
The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells
SIMPLE SUMMARY: The histone methyltransferase SET domain-containing protein 8 (SETD8) methylates histone H4 lysine 20 and non-histone proteins such as p53. Our aim was to determine the involvement of SETD8 in endometrial cancer and its therapeutic potential and identify the downstream genes regulate...
Autores principales: | Kukita, Asako, Sone, Kenbun, Kaneko, Syuzo, Kawakami, Eiryo, Oki, Shinya, Kojima, Machiko, Wada, Miku, Toyohara, Yusuke, Takahashi, Yu, Inoue, Futaba, Tanimoto, Saki, Taguchi, Ayumi, Fukuda, Tomohiko, Miyamoto, Yuichiro, Tanikawa, Michihiro, Mori-Uchino, Mayuyo, Tsuruga, Tetsushi, Iriyama, Takayuki, Matsumoto, Yoko, Nagasaka, Kazunori, Wada-Hiraike, Osamu, Oda, Katsutoshi, Hamamoto, Ryuji, Osuga, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655767/ https://www.ncbi.nlm.nih.gov/pubmed/36358786 http://dx.doi.org/10.3390/cancers14215367 |
Ejemplares similares
-
Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer
por: Wada, Miku, et al.
Publicado: (2020) -
The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation
por: Kojima, Machiko, et al.
Publicado: (2019) -
Characterization of a fluorescence imaging probe that exploits metabolic dependency of ovarian clear cell carcinoma
por: Tsuchimochi, Saki, et al.
Publicado: (2023) -
Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report
por: Sone, Kenbun, et al.
Publicado: (2020) -
Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications
por: Inoue, Futaba, et al.
Publicado: (2021)